Therapy of Chronic Lymphocytic Leukaemia with Purine Nucleoside Analogues
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 22 (12), 983-1012
- https://doi.org/10.2165/00002512-200522120-00002
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Richter syndromeCancer, 2005
- Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011Blood, 2005
- The clinical and epidemiological burden of chronic lymphocytic leukaemiaEuropean Journal of Cancer Care, 2004
- Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2003
- Purine Nucleoside Analogues in the Treatment of Myleoid LeukemiasLeukemia & Lymphoma, 2003
- Cellular and Clinical Pharmacology of FludarabineClinical Pharmacokinetics, 2002
- Cladribine in the Treatment of Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2001
- FludarabineDrugs, 1997
- In vivo‘Purging’ of residual disease in CLL with Campath‐1HBritish Journal of Haematology, 1997
- Infectious complications after 2‐chlorodeoxyadenosine therapyEuropean Journal of Haematology, 1996